We measured plasma CoP in MDD patients before and after manipulation of the HPA axis [i.e., stimulation (MET) and suppression (DEX)], along with plasma ACTH and CORT, in order to assess baseline and dynamic changes in all three levels of the axis and their correlation. The gene discussed is POMC; the disease is major depressive disorder.